Kyverna Therapeutics Ownership 2024 | Who Owns Kyverna Therapeutics Now?

Kyverna Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
PRUDENTIAL SECTOR FUNDS, INC.	0.13%	275,235	275,235	-	Feb 29, 2024
PRUDENTIAL JENNISON BLEND FUND, INC.	0.07%	42,610	42,610	-	Feb 29, 2024
BLACKROCK LARGE CAP SERIES FUNDS, INC.	0.00%	3,139	3,139	-	Feb 29, 2024
BLACKROCK FUNDS	0.00%	160,152	160,152	-	Feb 29, 2024
COLUMBIA FUNDS SERIES TRUST I	0.00%	36,583	36,583	-	Feb 29, 2024
FIRST TRUST EXCHANGE-TRADED FUND VIII	0.00%	65	65	-	Feb 29, 2024

Kyverna Therapeutics's largest mutual fund holder by % of total assets is "PRUDENTIAL SECTOR FUNDS, INC.", owning 275.24K shares, compromising 0.13% of its total assets.

Kyverna Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Feb 13, 2024	GILEAD SCIENCES, INC.	10 percent owner	-	P-Purchase	Buy	910,000	$22.00	$20.02M	4,126,119

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Feb 13, 2024	GILEAD SCIENCES, INC.	10 percent owner	-	P-Purchase	Buy	910,000	$22.00	$20.02M	4,126,119

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Feb 13, 2024	GILEAD SCIENCES, INC.	10 percent owner	-	C-Conversion	Sell	6,890,744	-	-	-
Feb 13, 2024	GILEAD SCIENCES, INC.	10 percent owner	-	C-Conversion	Sell	7,746,139	-	-	-
Feb 07, 2024	CLARK IAN T	director	-		Sell	38,736	$4.42	$171.21K	-
Feb 07, 2024	CLARK IAN T	director	-		Sell	43,945	$4.83	$212.25K	-
Feb 07, 2024	Kotzin Brian L.	director	-		Sell	43,306	$0.32	$13.86K	-
Feb 07, 2024	Kotzin Brian L.	director	-		Sell	32,959	$4.83	$159.19K	-
Feb 07, 2024	Maag Peter	director, officer	Chief Executive Officer		Sell	-	-	-	58,220
Feb 07, 2024	Maag Peter	director, officer	Chief Executive Officer		Sell	329,590	$4.83	$1.59M	-
Feb 07, 2024	Maag Peter	director, officer	Chief Executive Officer		Sell	1,098	$4.33	$4.75K	-
Feb 07, 2024	Maag Peter	director, officer	Chief Executive Officer		Sell	989,743	$3.15	$3.12M	-
Feb 07, 2024	GILEAD SCIENCES, INC.	10 percent owner	-		Sell	1,514,083	-	-	-
Feb 07, 2024	GILEAD SCIENCES, INC.	10 percent owner	-		Sell	1,702,036	-	-	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Feb 13, 2024	GILEAD SCIENCES, INC.	10 percent owner	-	P-Purchase	Buy	910,000	$22.00	$20.02M	4,126,119
Feb 13, 2024	GILEAD SCIENCES, INC.	10 percent owner	-	C-Conversion	Buy	3,216,119	-	-	3,216,119
Feb 13, 2024	GILEAD SCIENCES, INC.	10 percent owner	-	C-Conversion	Sell	6,890,744	-	-	-
Feb 13, 2024	GILEAD SCIENCES, INC.	10 percent owner	-	C-Conversion	Sell	7,746,139	-	-	-
Feb 07, 2024	CLARK IAN T	director	-		Sell	38,736	$4.42	$171.21K	-
Feb 07, 2024	CLARK IAN T	director	-		Sell	43,945	$4.83	$212.25K	-
Feb 07, 2024	Kotzin Brian L.	director	-		Sell	43,306	$0.32	$13.86K	-
Feb 07, 2024	Kotzin Brian L.	director	-		Sell	32,959	$4.83	$159.19K	-
Feb 07, 2024	Maag Peter	director, officer	Chief Executive Officer		Buy	-	-	-	349,321
Feb 07, 2024	Maag Peter	director, officer	Chief Executive Officer		Sell	-	-	-	58,220
Feb 07, 2024	Maag Peter	director, officer	Chief Executive Officer		Sell	329,590	$4.83	$1.59M	-
Feb 07, 2024	Maag Peter	director, officer	Chief Executive Officer		Sell	1,098	$4.33	$4.75K	-
Feb 07, 2024	Maag Peter	director, officer	Chief Executive Officer		Sell	989,743	$3.15	$3.12M	-
Feb 07, 2024	Bain Capital Life Sciences Investors, LLC	10 percent owner	-		Buy	2,713,868	-	-	-
Feb 07, 2024	GILEAD SCIENCES, INC.	10 percent owner	-		Sell	1,514,083	-	-	-
Feb 07, 2024	GILEAD SCIENCES, INC.	10 percent owner	-		Sell	1,702,036	-	-	-

The last insider sell of Kyverna Therapeutics's stock was made by GILEAD SCIENCES, INC. on Feb 13 2024, selling 6,890,744 shares at - per share (valued at -). The last insider buy of KYTX was made by GILEAD SCIENCES, INC. on Feb 13 2024, buying 910,000 shares at $22.00 per share (worth $20.02M).

Kyverna Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	2	11	18.18%
Q3 2022	-	1	-

2 total buy trades, and 11 total sell trades (buy/sell ratio of 0.18%) were made by Kyverna Therapeutics's insiders, as of Q1 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	1	-	-
Q3 2022	-	-	-

As of Q1 2024, Insider owners conducted 1 open market buy trades and 0 open market sell trades of Kyverna Therapeutics's stocks.